{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:43:26Z","timestamp":1782492206857,"version":"3.54.5"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"am","delay-in-days":261,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018188","name":"Clinical and Translational Science Institute, University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1UM1TR004405"],"award-info":[{"award-number":["1UM1TR004405"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bbi.2025.04.011","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T19:06:54Z","timestamp":1744398414000},"page":"336-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Human leukocyte antigen (HLA) class I and II genetic relationships with brain imaging measures: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"128","author":[{"given":"Lusi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengmin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2025.04.011_b0005","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.biopsych.2011.02.034","article-title":"Common sequence variants in the major histocompatibility complex region associate with cerebral ventricular size in schizophrenia","volume":"70","author":"Agartz","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.011_b0010","doi-asserted-by":"crossref","unstructured":"Andersen, M.H., Schrama, D., thor Straten, P., Becker, J.C., 2006. Cytotoxic T Cells. J. Invest. Dermatol. 126, 32\u201341. doi: 10.1038\/sj.jid.5700001.","DOI":"10.1038\/sj.jid.5700001"},{"key":"10.1016\/j.bbi.2025.04.011_b0015","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","article-title":"The immunology of multiple sclerosis","volume":"22","author":"Attfield","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bbi.2025.04.011_b0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2377-13-77","article-title":"The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania","volume":"13","author":"Balnyte","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.bbi.2025.04.011_b0025","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac078","article-title":"The role of critical immune genes in brain disorders: insights from neuroimaging immunogenetics","volume":"4","author":"Bian","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.bbi.2025.04.011_b0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/13524585221130941","article-title":"HLA-DRB1*1501 influences long-term disability progression and tissue damage on MRI in relapse-onset multiple sclerosis","volume":"29","author":"Brownlee","year":"2023","journal-title":"Multiple Sclerosis (houndmills, Basingstoke, England)"},{"key":"10.1016\/j.bbi.2025.04.011_b0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbi.2015.02.021","article-title":"A schizophrenia-associated HLA locus affects thalamus volume and asymmetry","volume":"46","author":"Brucato","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.04.011_b0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1352458509350741","article-title":"HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis","volume":"16","author":"Brum","year":"2010","journal-title":"Multiple Sclerosis (houndmills, Basingstoke, England)"},{"key":"10.1016\/j.bbi.2025.04.011_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-023-05496-5","article-title":"HLA allele-calling using multi-ancestry whole-exome sequencing from the UK Biobank identifies 129 novel associations in 11 autoimmune diseases","volume":"6","author":"Butler-Laporte","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.bbi.2025.04.011_b0050","doi-asserted-by":"crossref","first-page":"1765.e7","DOI":"10.1016\/j.neurobiolaging.2014.12.028","article-title":"Association of Alzheimer\u2019s disease GWAS loci with MRI markers of brain aging","volume":"36","author":"Chauhan","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2025.04.011_b0055","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/791238","article-title":"Alzheimer\u2019s Disease and HLA-A2: Linking Neurodegenerative to Immune Processes through an In Silico Approach","volume":"2014","author":"Cifuentes","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.bbi.2025.04.011_b0060","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1152\/physrev.00039.2016","article-title":"Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa","volume":"98","author":"Dantzer","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bbi.2025.04.011_b0065","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nri.2017.143","article-title":"HLA variation and disease","volume":"18","author":"Dendrou","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bbi.2025.04.011_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002877","article-title":"Multi-population classical HLA type imputation","volume":"9","author":"Dilthey","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.bbi.2025.04.011_b0075","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41586-018-0571-7","article-title":"Genome-wide association studies of brain imaging phenotypes in UK Biobank","volume":"562","author":"Elliott","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2025.04.011_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116768","article-title":"Risk HLA-DRB1 alleles differentially influence brain and lesion volumes in Japanese patients with multiple sclerosis","volume":"413","author":"Fukumoto","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbi.2025.04.011_b0085","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/WNL.57.11.1976","article-title":"HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis","volume":"57","author":"Fusco","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2025.04.011_b0090","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bbi.2023.10.019","article-title":"HLA-C*07:01 and HLA-DQB1*02:01 protect against white matter hyperintensities and deterioration of cognitive function: A population-based cohort study","volume":"115","author":"Gao","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.04.011_b0095","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/1352458518763541","article-title":"Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis","volume":"25","author":"Graetz","year":"2019","journal-title":"Multiple Sclerosis (houndmills, Basingstoke, England)"},{"key":"10.1016\/j.bbi.2025.04.011_b0100","doi-asserted-by":"crossref","unstructured":"Healy, M.J., Lincoln, M.R., Dyment, D.A., Ramagopalan, S.V., Ebers, G.C., 2010. HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology, Comment on: Neurology. 2010 Aug 17;75(7):634-40 PMID: 20713950 [https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20713950] 77, 602\u20133. doi: 10.1212\/WNL.0b013e318219a17e.","DOI":"10.1212\/WNL.0b013e318219a17e"},{"key":"10.1016\/j.bbi.2025.04.011_b0105","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s Disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bbi.2025.04.011_b0110","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.bbi.2025.04.011_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053996","article-title":"Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study","volume":"8","author":"Horakova","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2025.04.011_b0120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneuroim.2011.04.011","article-title":"HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event","volume":"236","author":"Horakova","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2025.04.011_b0125","unstructured":"International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer, S., Hellenthal, G., Pirinen, M., Spencer, C.C.A., Patsopoulos, N.A., Moutsianas, L., Dilthey, A., Su, Z., Freeman, C., Hunt, S.E., Edkins, S., Gray, E., Booth, D.R., Potter, S.C., Goris, A., Band, G., Oturai, A.B., Strange, A., Saarela, J., Bellenguez, C., Fontaine, B., Gillman, M., Hemmer, B., Gwilliam, R., Zipp, F., Jayakumar, A., Martin, R., Leslie, S., Hawkins, S., Giannoulatou, E., D\u2019alfonso, S., Blackburn, H., Martinelli Boneschi, F., Liddle, J., Harbo, H.F., Perez, M.L., Spurkland, A., Waller, M.J., Mycko, M.P., Ricketts, M., Comabella, M., Hammond, N., Kockum, I., McCann, O.T., Ban, M., Whittaker, P., Kemppinen, A., Weston, P., Hawkins, C., Widaa, S., Zajicek, J., Dronov, S., Robertson, N., Bumpstead, S.J., Barcellos, L.F., Ravindrarajah, R., Abraham, R., Alfredsson, L., Ardlie, K., Aubin, C., Baker, A., Baker, K., Baranzini, S.E., Bergamaschi, L., Bergamaschi, R., Bernstein, A., Berthele, A., Boggild, M., Bradfield, J.P., Brassat, D., Broadley, S.A., Buck, D., Butzkueven, H., Capra, R., Carroll, W.M., Cavalla, P., Celius, E.G., Cepok, S., Chiavacci, R., Clerget-Darpoux, F., Clysters, K., Comi, G., Cossburn, M., Cournu-Rebeix, I., Cox, M.B., Cozen, W., Cree, B.A.C., Cross, A.H., Cusi, D., Daly, M.J., Davis, E., de Bakker, P.I.W., Debouverie, M., D\u2019hooghe, M.B., Dixon, K., Dobosi, R., Dubois, B., Ellinghaus, D., Elovaara, I., Esposito, F., Fontenille, C., Foote, S., Franke, A., Galimberti, D., Ghezzi, A., Glessner, J., Gomez, R., Gout, O., Graham, C., Grant, S.F.A., Guerini, F.R., Hakonarson, H., Hall, P., Hamsten, A., Hartung, H.-P., Heard, R.N., Heath, S., Hobart, J., Hoshi, M., Infante-Duarte, C., Ingram, G., Ingram, W., Islam, T., Jagodic, M., Kabesch, M., Kermode, A.G., Kilpatrick, T.J., Kim, C., Klopp, N., Koivisto, K., Larsson, M., Lathrop, M., Lechner-Scott, J.S., Leone, M.A., Lepp\u00e4, V., Liljedahl, U., Bomfim, I.L., Lincoln, R.R., Link, J., Liu, J., Lorentzen, A.R., Lupoli, S., Macciardi, F., Mack, T., Marriott, M., Martinelli, V., Mason, D., McCauley, J.L., Mentch, F., Mero, I.-L., Mihalova, T., Montalban, X., Mottershead, J., Myhr, K.-M., Naldi, P., Ollier, W., Page, A., Palotie, A., Pelletier, J., Piccio, L., Pickersgill, T., Piehl, F., Pobywajlo, S., Quach, H.L., Ramsay, P.P., Reunanen, M., Reynolds, R., Rioux, J.D., Rodegher, M., Roesner, S., Rubio, J.P., R\u00fcckert, I.-M., Salvetti, M., Salvi, E., Santaniello, A., Schaefer, C.A., Schreiber, S., Schulze, C., Scott, R.J., Sellebjerg, F., Selmaj, K.W., Sexton, D., Shen, L., Simms-Acuna, B., Skidmore, S., Sleiman, P.M.A., Smestad, C., S\u00f8rensen, P.S., S\u00f8ndergaard, H.B., Stankovich, J., Strange, R.C., Sulonen, A.-M., Sundqvist, E., Syv\u00e4nen, A.-C., Taddeo, F., Taylor, B., Blackwell, J.M., Tienari, P., Bramon, E., Tourbah, A., Brown, M.A., Tronczynska, E., Casas, J.P., Tubridy, N., Corvin, A., Vickery, J., Jankowski, J., Villoslada, P., Markus, H.S., Wang, K., Mathew, C.G., Wason, J., Palmer, C.N.A., Wichmann, H.-E., Plomin, R., Willoughby, E., Rautanen, A., Winkelmann, J., Wittig, M., Trembath, R.C., Yaouanq, J., Viswanathan, A.C., Zhang, H., Wood, N.W., Zuvich, R., Deloukas, P., Langford, C., Duncanson, A., Oksenberg, J.R., Pericak-Vance, M.A., Haines, J.L., Olsson, T., Hillert, J., Ivinson, A.J., De Jager, P.L., Peltonen, L., Stewart, G.J., Hafler, D.A., Hauser, S.L., McVean, G., Donnelly, P., Compston, A., 2011. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214\u2013219. doi: 10.1038\/nature10251."},{"key":"10.1016\/j.bbi.2025.04.011_b0130","doi-asserted-by":"crossref","unstructured":"Isobe, N., Keshavan, A., Gourraud, P.-A., Zhu, A.H., Datta, E., Schlaeger, R., Caillier, S.J., Santaniello, A., Lizee, A., Himmelstein, D.S., Baranzini, S.E., Hollenbach, J., Cree, B.A.C., Hauser, S.L., Oksenberg, J.R., Henry, R.G., 2016. Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis. JAMA neurology, Comment in: JAMA Neurol. 2016 Jul 1;73(7):777-8 PMID: 27244583 [https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27244583] Comment in: JAMA Neurol. 2016 Dec 1;73(12):1501-1502 PMID: 27775754 [https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27775754] Comment in: JAMA Neurol. 2016 Dec 1;73(12):1500-1501 PMID: 27775759 [https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27775759] 73, 795\u2013802. doi: 10.1001\/jamaneurol.2016.0980.","DOI":"10.1001\/jamaneurol.2016.0980"},{"key":"10.1016\/j.bbi.2025.04.011_b0135","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ebiom.2017.11.005","article-title":"Human Leukocyte Antigen (HLA) and Gulf War Illness (GWI): HLA-DRB1*13:02 spares subcortical atrophy in gulf war veterans","volume":"26","author":"James","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbi.2025.04.011_b0140","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00221-022-06382-y","article-title":"BOLD turnover in task-free state: variation among brain areas and effects of age and human leukocyte antigen (HLA) DRB1*13","volume":"240","author":"James","year":"2022","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.bbi.2025.04.011_b0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ebiom.2018.02.005","article-title":"Protective Effect of Human Leukocyte Antigen (HLA) Allele DRB1*13:02 on age-related brain gray matter volume reduction in healthy women","volume":"29","author":"James","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbi.2025.04.011_b0150","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jneuroim.2012.08.011","article-title":"Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients","volume":"254","author":"Karrenbauer","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2025.04.011_b0155","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","article-title":"The case of the misleading funnel plot","volume":"333","author":"Lau","year":"2006","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.bbi.2025.04.011_b9000","volume":"8","author":"Lassmann","year":"2018","journal-title":"Multiple Sclerosis Pathology Cold Spring Harb Perspect Med."},{"key":"10.1016\/j.bbi.2025.04.011_b0160","doi-asserted-by":"crossref","unstructured":"Le Guen, Y., Luo, G., Ambati, A., Damotte, V., Jansen, I., Yu, E., Nicolas, A., de Rojas, I., Peixoto Leal, T., Miyashita, A., Bellenguez, C., Lian, M.M., Parveen, K., Morizono, T., Park, H., Grenier-Boley, B., Naito, T., K\u00fc\u00e7\u00fckali, F., Talyansky, S.D., Yogeshwar, S.M., Sempere, V., Satake, W., Alvarez, V., Arosio, B., Belloy, M.E., Benussi, L., Boland, A., Borroni, B., Bullido, M.J., Caffarra, P., Clarimon, J., Daniele, A., Darling, D., Debette, S., Deleuze, J.-F., Dichgans, M., Dufouil, C., During, E., D\u00fczel, E., Galimberti, D., Garcia-Ribas, G., Garc\u00eda-Alberca, J.M., Garc\u00eda-Gonz\u00e1lez, P., Giedraitis, V., Goldhardt, O., Graff, C., Gr\u00fcnblatt, E., Hanon, O., Hausner, L., Heilmann-Heimbach, S., Holstege, H., Hort, J., Jung, Y.J., J\u00fcrgen, D., Kern, S., Kuulasmaa, T., Lee, K.H., Lin, L., Masullo, C., Mecocci, P., Mehrabian, S., de Mendon\u00e7a, A., Boada, M., Mir, P., Moebus, S., Moreno, F., Nacmias, B., Nicolas, G., Niida, S., Nordestgaard, B.G., Papenberg, G., Papma, J., Parnetti, L., Pasquier, F., Pastor, P., Peters, O., Pijnenburg, Y.A.L., Pi\u00f1ol-Ripoll, G., Popp, J., Porcel, L.M., Puerta, R., P\u00e9rez-Tur, J., Rainero, I., Ramakers, I., Real, L.M., Riedel-Heller, S., Rodriguez-Rodriguez, E., Ross, O.A., Royo, J.L., Rujescu, D., Scarmeas, N., Scheltens, P., Scherbaum, N., Schneider, A., Seripa, D., Skoog, I., Solfrizzi, V., Spalletta, G., Squassina, A., van Swieten, J., S\u00e1nchez-Valle, R., Tan, E.-K., Tegos, T., Teunissen, C., Thomassen, J.Q., Tremolizzo, L., Vyhnalek, M., Verhey, F., Waern, M., Wiltfang, J., Zhang, J., EADB, GR@ACE study group, DEGESCO consortium, DemGene, EADI, GERAD, Asian Parkinson\u2019s Disease Genetics consortium, Zetterberg, H., Blennow, K., He, Z., Williams, J., Amouyel, P., Jessen, F., Kehoe, P.G., Andreassen, O.A., Van Duin, C., Tsolaki, M., S\u00e1nchez-Juan, P., Frikke-Schmidt, R., Sleegers, K., Toda, T., Zettergren, A., Ingelsson, M., Okada, Y., Rossi, G., Hiltunen, M., Gim, J., Ozaki, K., Sims, R., Foo, J.N., van der Flier, W., Ikeuchi, T., Ramirez, A., Mata, I., Ruiz, A., Gan-Or, Z., Lambert, J.-C., Greicius, M.D., Mignot, E., 2023. Multiancestry analysis of the HLA locus in Alzheimer\u2019s and Parkinson\u2019s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes. Proceedings of the National Academy of Sciences 120, e2302720120. doi: 10.1073\/pnas.2302720120.","DOI":"10.1073\/pnas.2302720120"},{"key":"10.1016\/j.bbi.2025.04.011_b0165","first-page":"124","article-title":"Genetic variation affecting exon skipping contributes to brain structural atrophy in Alzheimer\u2019s disease","volume":"2017","author":"Lee","year":"2018","journal-title":"AMIA Joint Summits on Transl. Sci."},{"key":"10.1016\/j.bbi.2025.04.011_b0170","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/phar.2887","article-title":"A systematic review of clozapine-associated inflammation and related monitoring","volume":"43","author":"Leung","year":"2023","journal-title":"Pharmacother.: J. Human Pharmacol. Drug Therapy"},{"key":"10.1016\/j.bbi.2025.04.011_b0175","doi-asserted-by":"crossref","first-page":"e1562","DOI":"10.1212\/WNL.0000000000200006","article-title":"Relationship between white matter lesions and gray matter atrophy in multiple sclerosis","volume":"98","author":"Lie","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2025.04.011_b0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/gene.2010.58","article-title":"HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study","volume":"12","author":"Liguori","year":"2011","journal-title":"Genes Immun."},{"key":"10.1016\/j.bbi.2025.04.011_b0190","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jns.2017.02.019","article-title":"HLA genotype as a marker of multiple sclerosis prognosis: A pilot study","volume":"375","author":"Lysandropoulos","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbi.2025.04.011_b0195","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1017\/cjn.2019.329","article-title":"Human leukocyte antigen genotype as a marker of multiple sclerosis prognosis","volume":"47","author":"Lysandropoulos","year":"2020","journal-title":"J. Can. Sci. Neurol."},{"key":"10.1016\/j.bbi.2025.04.011_b0200","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.tig.2021.04.012","article-title":"Multiple sclerosis: doubling down on MHC","volume":"37","author":"Martin","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbi.2025.04.011_b0205","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/1531-8249(200008)48:2<211::AID-ANA11>3.0.CO;2-R","article-title":"HLA-DR15 is associated with lower age at onset in multiple sclerosis","volume":"48","author":"Masterman","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbi.2025.04.011_b0210","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/1352458508097818","article-title":"Association of the HLA-DRB1 alleles with characteristic MRI features of Asian multiple sclerosis","volume":"14","author":"Matsuoka","year":"2008","journal-title":"Multiple Sclerosis (houndmills, Basingstoke, England)"},{"key":"10.1016\/j.bbi.2025.04.011_b0215","doi-asserted-by":"crossref","unstructured":"Moutsianas, L., Jostins, L., Beecham, A.H., Dilthey, A.T., Xifara, D.K., Ban, M., Shah, T.S., Patsopoulos, N.A., Alfredsson, L., Anderson, C.A., Attfield, K.E., Baranzini, S.E., Barrett, J., Binder, T.M.C., Booth, D., Buck, D., Celius, E.G., Cotsapas, C., D\u2019Alfonso, S., Dendrou, C.A., Donnelly, P., Dubois, B., Fontaine, B., Fugger, L., Goris, A., Gourraud, P.-A., Graetz, C., Hemmer, B., Hillert, J., International IBD Genetics Consortium (IIBDGC), Kockum, I., Leslie, S., Lill, C.M., Martinelli-Boneschi, F., Oksenberg, J.R., Olsson, T., Oturai, A., Saarela, J., S\u00f8ndergaard, H.B., Spurkland, A., Taylor, B., Winkelmann, J., Zipp, F., Haines, J.L., Pericak-Vance, M.A., Spencer, C.C.A., Stewart, G., Hafler, D.A., Ivinson, A.J., Harbo, H.F., Hauser, S.L., De Jager, P.L., Compston, A., McCauley, J.L., Sawcer, S., McVean, G., 2015. Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat. Genet. 47, 1107\u20131113. doi: 10.1038\/ng.3395.","DOI":"10.1038\/ng.3395"},{"key":"10.1016\/j.bbi.2025.04.011_b0220","doi-asserted-by":"crossref","unstructured":"Muniz-Castrillo, S., Haesebaert, J., Thomas, L., Vogrig, A., Pinto, A.-L., Picard, G., Blanc, C., Do, L.-D., Joubert, B., Berzero, G., Psimaras, D., Alentorn, A., Rogemond, V., Dubois, V., Ambati, A., Tamouza, R., Mignot, E., Honnorat, J., 2021. Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis. Neurology(R) neuroimmunology & neuroinflammation 8. doi: 10.1212\/NXI.0000000000000974.","DOI":"10.1212\/NXI.0000000000000974"},{"key":"10.1016\/j.bbi.2025.04.011_b0225","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1590\/0004-282x-anp-2020-0487","article-title":"HLA-DQA1*04:01 is related to a higher multiple sclerosis lesion load on T2\/Flair MRI sequences","volume":"79","author":"Noro","year":"2021","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.bbi.2025.04.011_b0230","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"10.1016\/j.bbi.2025.04.011_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-024-00758-3","article-title":"A worldwide study of white matter microstructural alterations in people living with Parkinson\u2019s disease","volume":"10","author":"Owens-Walton","year":"2024","journal-title":"Npj Parkinsons Dis."},{"key":"10.1016\/j.bbi.2025.04.011_b0240","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","article-title":"The immune response in multiple sclerosis","volume":"17","author":"Rodr\u00edguez Mur\u00faa","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bbi.2025.04.011_b0245","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad255","article-title":"Genetic influences on disease course and severity, 30 years after a clinically isolated syndrome","volume":"5","author":"Sahi","year":"2023","journal-title":"Brain Commun."},{"key":"10.1016\/j.bbi.2025.04.011_b0250","article-title":"Tutorial: a statistical genetics guide to identifying HLA alleles driving complex disease","volume":"1\u201317","author":"Sakaue","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbi.2025.04.011_b0255","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.bbi.2025.04.011_b0260","doi-asserted-by":"crossref","DOI":"10.3390\/genes13112136","article-title":"Exploring the association of HLA genetic risk burden on thalamic and hippocampal atrophy in multiple sclerosis patients","volume":"13","author":"Santoro","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.bbi.2025.04.011_b0265","article-title":"Meta-Analysis with R, Use R!","author":"Schwarzer","year":"2015","journal-title":"Springer International Publishing, Cham."},{"key":"10.1016\/j.bbi.2025.04.011_b0270","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuron.2009.09.044","article-title":"MHC Class I: an unexpected role in neuronal plasticity","volume":"64","author":"Shatz","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2025.04.011_b0275","doi-asserted-by":"crossref","unstructured":"Shinoda, K., Matsushita, T., Nakamura, Y., Masaki, K., Yamasaki, R., Yamaguchi, H., Togao, O., Hiwatashi, A., Kira, J.-I., 2018. HLA-DRB1*04:05 allele is associated with intracortical lesions on three-dimensional double inversion recovery images in Japanese patients with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), Comment in: Mult Scler. 2018 May;24(6):818-819 PMID: 28994637 [https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28994637] Comment in: Mult Scler. 2018 May;24(6):819-820 PMID: 28994641 [https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28994641] Erratum in: Mult Scler. 2018 May;24(6):NP1 PMID: 29665735 [https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29665735] 24, 710\u2013720. doi: 10.1177\/1352458517707067.","DOI":"10.1177\/1352458517707067"},{"key":"10.1016\/j.bbi.2025.04.011_b0280","doi-asserted-by":"crossref","unstructured":"Sombekke, M.H., Lukas, C., Crusius, J.B.A., Tejedor, D., Killestein, J., Arteta, D., Martinez, A., Uitdehaag, B.M.J., Knol, D.L., Pena, A.S., Geurts, J.J.G., De Jager, P.L., Barkhof, F., Vrenken, H., Polman, C.H., 2009. HLA-DRB1*1501 and spinal cord magnetic resonance imaging lesions in multiple sclerosis. Arch. Neurology, Erratum in: Arch Neurol. 2010 Apr;67(4):514 66, 1531\u20136. doi: 10.1001\/archneurol.2009.278.","DOI":"10.1001\/archneurol.2009.278"},{"key":"10.1016\/j.bbi.2025.04.011_b0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.bbi.2025.04.011_b0290","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.bbi.2020.09.033","article-title":"Understanding the genetic contribution of the human leukocyte antigen system to common major psychiatric disorders in a world pandemic context","volume":"91","author":"Tamouza","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.04.011_b0295","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1253","article-title":"Reduced cortical thickness related to single nucleotide polymorphisms in the major histocompatibility complex region in antipsychotic-naive schizophrenia","volume":"9","author":"Tao","year":"2019","journal-title":"Brain and Behavior"},{"key":"10.1016\/j.bbi.2025.04.011_b0300","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1212\/WNL.0000000000000959","article-title":"HLA-DRB1*15 influences the development of brain tissue damage in early PPMS","volume":"83","author":"Tur","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2025.04.011_b0305","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/1352458510389101","article-title":"Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition","volume":"17","author":"Van der Walt","year":"2011","journal-title":"Multiple Sclerosis (Houndmills, Basingstoke, England)"},{"key":"10.1016\/j.bbi.2025.04.011_b0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.bbi.2025.04.011_b0320","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.cell.2020.09.054","article-title":"HLA-DR15 molecules jointly shape an autoreactive T cell repertoire in multiple sclerosis","volume":"183","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2025.04.011_b0325","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s12017-020-08612-4","article-title":"HLA in Alzheimer\u2019s disease: genetic association and possible pathogenic roles","volume":"22","author":"Wang","year":"2020","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.bbi.2025.04.011_b0330","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1007\/s12035-016-9889-z","article-title":"Genetic association of HLA gene variants with MRI brain structure in Alzheimer\u2019s disease","volume":"54","author":"Wang","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbi.2025.04.011_b0335","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1007\/s12035-016-9890-6","article-title":"Effects of HLA-DRB1\/DQB1 genetic variants on neuroimaging in healthy, mild cognitive impairment, and Alzheimer\u2019s disease cohorts","volume":"54","author":"Wang","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbi.2025.04.011_b0340","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1007\/s12035-016-9832-3","article-title":"HLA-A2 alleles mediate alzheimer\u2019s disease by altering hippocampal volume","volume":"54","author":"Wang","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbi.2025.04.011_b0345","series-title":"Multiple Sclerosis and Related Disorders, Comment. in: Mult Scler Relat Disord","article-title":"HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis","author":"Yaldizli","year":"2016"},{"key":"10.1016\/j.bbi.2025.04.011_b0350","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0074-7742(07)79023-2","article-title":"HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis","volume":"79","author":"Zivadinov","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.bbi.2025.04.011_b0355","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00415-003-0164-7","article-title":"HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis","volume":"250","author":"Zivadinov","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbi.2025.04.011_b0360","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2009.01.023","article-title":"Gene-environment interactions between HLA B7\/A2, EBV antibodies are associated with MRI injury in multiple sclerosis","volume":"209","author":"Zivadinov","year":"2009","journal-title":"J. Neuroimmunol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125001333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125001333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:37:58Z","timestamp":1763444278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125001333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":71,"alternative-id":["S0889159125001333"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.04.011","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human leukocyte antigen (HLA) class I and II genetic relationships with brain imaging measures: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}